UBS Group
ETNB

UBS Group’s 89bio ETNB Stock Holding History

UBS Group’s Portfolio ETNB Stock Details ETNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-343,600
Closed -$5.05M – 10680
2025
Q3 		$5.05M Buy
+343,600
New +$3.5M ﹤0.01% 4021

Other funds holding ETNB

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

UBS Group's ETNB Position: Q4 2025 in Review

UBS Group sold out of 89bio (ETNB) in Q4 2025, closing a stake of 666,842 shares — an estimated $9.8M sold.

UBS Group first reported a position in ETNB in Q4 2019 and held it in 24 quarters. The position peaked at $9.8M in Q3 2025. 2 funds tracked by Wall St. Rank hold ETNB as of Q4 2025.

  • UBS Group reported no remaining 89bio position as of Q4 2025 after selling out during the quarter.
  • UBS Group sold 666,842 89bio shares in Q4 2025, an estimated $9.8M.
  • UBS Group first reported a position in 89bio in Q4 2019 and held it in 24 quarters.
  • UBS Group's 89bio position peaked at $9.8M in Q3 2025.
  • 2 funds tracked by Wall St. Rank held 89bio as of Q4 2025.

Based on UBS Group's 13F filing for Q4 2025, filed 29 Jan 2026.